AstraZeneca optimizing anti-inflammatory reliever therapy

Please join us virtually for a presentation on optimizing anti-inflammatory reliever therapy: Anti-inflammatory reliever reduces exacerbations. A fundamental change in approach to treating asthma. This program is supported in part by an educational grant from AstraZeneca.

Speakers:

• Dr. Amanda Jagdis, Allergist
• Moderator: Dr. Walter Chow

Learning objectives:

• Describe the latest asthma treatment recommendations from the Global, Initiative for Asthma (GINA) and the Canadian Thoracic Society (CTS)
• Discuss why over-reliance on short-acting beta-agonists (SABA) increases risk of exacerbations and worsening asthma
• Discuss recent evidence on anti-inflammatory reliever reducing asthma exacerbations
• Identify strategies to transition patients from SABA as a reliever to anti-inflammatory reliever

How to join:

• Registration required https://us02web.zoom.us/meeting/register/tZ0kce2qqDItGNEquxUm4kpLC6JD5aeU1BIv
  after registering, you will receive a confirmation email containing the zoom information to join. 
• More information (PDF)

CME: This one-credit-per-hour Group Learning program has been certified by the College of Family Physicians of Canada and the British Columbia Chapter for 1.0 Mainpro+ credit.

Disclaimer: The CME Event Calendar contains information originating from other sources. While every attempt is made to ensure that all information is accurately referenced, we do not guarantee the accuracy, quality or CME accreditation of posted events. Before registering for this event, please refer to the provincially harmonized CME Policy regarding reimbursement requirements for courses and conferences.